Amgen (AMGN) Change in Taxes (2009 - 2026)

Amgen (AMGN) has reported Change in Taxes for 18 consecutive years, with $71.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Taxes fell 31.73% year-over-year to $71.0 million; the TTM figure through Mar 2026 stood at -$2.1 billion (down 85.93% YoY), while the FY2025 annual figure was -$2.1 billion, down 104.55% from the prior year.
• Change in Taxes came in at $71.0 million for Q1 2026 at Amgen, up from -$365.0 million in the prior quarter.
• The five-year high for Change in Taxes was $610.0 million in Q3 2025, with the low at -$2.4 billion in Q2 2025.
• Average Change in Taxes over 5 years is -$275.6 million, with a median of $71.0 million recorded in 2026.
• Across the five-year window, Change in Taxes jumped 511.54% in 2022 and tumbled 5578.57% in 2024, its largest moves.
• Year by year, Change in Taxes stood at -$155.0 million in 2022, then slumped by 1209.03% to -$2.0 billion in 2023, then jumped by 102.61% to $53.0 million in 2024, then tumbled by 788.68% to -$365.0 million in 2025, then jumped by 119.45% to $71.0 million in 2026.
• According to Business Quant data, Change in Taxes over the past three periods registered $71.0 million, -$365.0 million, and $610.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.